Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/9/2018
SIETES contiene 92557 citas

 
 
 1 a 20 de 105 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Perkins GD, Ji C, Deakin CD, Quinn T, Nolan JP, Scomparin C, Regan S, Long J, Slowther A, Pocock H, Black JJM, Moore F, Fothergill RT, Rees N, O'Shea L, Docherty M, Gunson I, Han K, Charlton K, Finn J, Petrou S, Stallard N, Gates S, Lall R, for the PARAMEDIC2 Collaborators. A randomized trial of epinephrine in out-of-hospital cardiac arrest. N Engl J Med 2018;379:711-21. [Ref.ID 102822]
2. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
3. Cita con resumen
Poluzzi E, Diemberger I, de Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. Eur J Clin Pharmacol 2017;73:1499-510. [Ref.ID 102126]
4. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
5. Cita con resumen
Anónimo. Décongestionnants rhinopharyngés: fibrillations auriculaires. Prescrire 2017;37:24. [Ref.ID 101364]
6.Tiene citas relacionadas Cita con resumen
Anónimo. In brief: oral phenylephrine for nasal congestion. The Medical Letter on Drug and Therapeutics Bulletin 2015;57:174. [Ref.ID 99738]
7.Tiene citas relacionadas Cita con resumen
Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. J Allergy Clin Immunol 2015;3:702-8. [Ref.ID 99480]
8. Cita con resumen
Anónimo. Ivermectin cream (Soolantra) for rosacea. Med Lett Drugs Ther 2015;57:51-2. [Ref.ID 99234]
9. Cita con resumen
Anónimo. FDA expands uses of Vyvanse to treat binge-eating disorder. FDA U.S. Food and Drug Administration 2015:30 de enero. [Ref.ID 98748]
10. Cita con resumen
Atkinson HC, Anderson BJ. Increased phenylephrine plasma levels with administration of acetaminophen. N Engl J Med 2014;370:1171-2. [Ref.ID 97313]
11. Cita con resumen
Anónimo. Pour mieux soigner: des médicaments à écarter. Prescrire 2013;33:138-42. [Ref.ID 94882]
12. Cita con resumen
Anónimo. Midodrine: troubles cardiovasculaires et cutanés. Prescrire 2012;32:352. [Ref.ID 92807]
13. Cita con resumen
Anónimo. Topical phenylephrine pulmonary oedema. Australia. WHO Pharmaceuticals Newsletter 2012;3:12. [Ref.ID 92776]
14. Cita con resumen
Montastruc J-L. Médicaments déterminant HTA : du nouveau !. BIP31.fr 2012;19:19-20. [Ref.ID 92664]
15. Cita con resumen
16. Cita con resumen
Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365:1896-904. [Ref.ID 91594]
17. Cita con resumen
Wuerstle MC, Van Den Eeden SK, Poon KT, Quinn VP, Hollingworth JM, Loo RK, Jacobsen SJ, for the Urologic Diseases in America Project. Contribution of common medications to lower urinary tract symptoms in men. Arch Intern Med 2011;171:1680-2. [Ref.ID 91542]
18.
Senard-Ojero A, Durrieu G, Depiesse F, Schmitt L, Riviere D, Montastruc J-L. Consommation de substances interdites chez le sportif: étude à l'Antenne Médicale de Prévention du Dopage de Midi-Pyrénées (AMPD-MP). Therapie 2010;65:459-63. [Ref.ID 89879]
19. Cita con resumen
Watson R. EU drug agency voices concern over cuts in drug treatment programmes. BMJ 2010;341:1073. [Ref.ID 89691]
20. Cita con resumen
Dhruva SS, Redberg RF. Accelerated approval and possible withdrawal of midodrine. JAMA 2010;304:2172-3. [Ref.ID 89668]
Seleccionar todas
 
 1 a 20 de 105 siguiente >>